Ebola outbreak in Democratic Republic of Congo passes grim milestone of 2,000 deaths

The death toll from the ongoing Ebola outbreak in the Democratic Republic of Congo has surged past 2,011, according to the latest official figures released by national health authorities. With 4,381 confirmed cases recorded, health officials warn this crisis may soon surpass all previous outbreaks in the country’s history.

The path to 1,000 fatalities took nearly nine weeks, yet the next 1,000 deaths were recorded in just three weeks—a stark indication that the outbreak is accelerating far faster than containment and response efforts.

Authorities cite severe challenges in delivering critical medical aid to remote communities. Ongoing rebel conflicts, deteriorating road networks, and widespread strikes—sparked by unpaid wages among healthcare workers—have severely hampered response operations.

Dr. Jean-Marie Akandabo, overseeing patient care at a local clinic in Ituri Province, described the situation as alarming and urgently called for intensified efforts in the hardest-hit areas.

This marks the 17th recorded outbreak of Ebola in the DRC, already recognized as the most extensive in the nation’s history. This outbreak could well become the largest ever recorded, cautioned Sania Nishtar, CEO of Gavi, the Vaccine Alliance.

The current fatality rate stands at 45.9%, significantly higher than the 39.6% recorded during the devastating West Africa Ebola epidemic of 2014–2016, which claimed over 11,000 lives from nearly 28,000 cases. That outbreak remains the deadliest in recorded history.

Public health emergency declared

Although the outbreak was declared on May 15, genetic sequencing of the virus suggests the epidemic began several months earlier, in February. The government has since declared a national public health emergency.

This outbreak differs from previous ones because it is driven by the rare Bundibugyo strain of Ebola, for which no approved vaccines or treatments currently exist. Clinical trials for potential vaccines have begun in Ituri Province, the epicenter of the crisis.

Humanitarian teams report that the virus continues to outpace response efforts across the five affected provinces in eastern DRC. Many healthcare workers have gone on strike due to unpaid salaries since the outbreak was declared. The World Health Organization has noted that most new cases are being detected outside monitored contact tracing chains, signaling that transmission remains largely uncontrolled.

Without an effective vaccine, controlling this outbreak relies entirely on identifying cases early and isolating patients in secure treatment centers until recovery—or, tragically, death, explained Professor Paul Hunter of the University of East Anglia in the United Kingdom. In a conflict zone with disrupted communications, routine surveillance becomes nearly impossible, making early detection and containment extremely difficult, if not impossible.

On Friday, WHO vaccine experts recommended initiating a large-scale human trial using the only currently licensed Ebola vaccine, Ervebo, to assess whether it provides cross-protection against the Bundibugyo strain currently circulating in DRC, for which no specific vaccine yet exists.

Ervebo has proven safe and effective against the more common Zaire strain of Ebola. Preliminary data, including animal studies, suggest it may offer some protection against the rare Bundibugyo strain driving the current outbreak.

Two experimental vaccines for the Bundibugyo strain are in early-stage human trials, while a third is in preclinical development.

Dr. Mohamed Yahya Janabi, WHO’s Regional Director for Africa, warned that officials are running behind the virus, which has gained a dangerous head start.

Ebola spreads through contact with bodily fluids and causes severe hemorrhagic fever. First identified in 1976 near the Ebola River in what is now the DRC, this deadly virus has resurfaced repeatedly, with each outbreak posing new challenges to global health systems.